Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Baltimore, MD 21224, USA.
Drug Alcohol Depend. 2012 Jun 1;123(1-3):141-7. doi: 10.1016/j.drugalcdep.2011.11.007. Epub 2011 Dec 7.
Cannabis withdrawal occurs in frequent users who quit, but there are no accepted diagnostic criteria for a cannabis withdrawal syndrome (CWS). This study evaluated diagnostic criteria for CWS proposed in DSM-V and two earlier proposals.
A convenience sample of 384 adult, non-treatment-seeking lifetime cannabis smokers provided retrospective self-report data on their "most difficult" quit attempt without formal treatment, which was used in this secondary analysis. Prevalence, time of onset, and peak intensity (5-point Likert scale) for 39 withdrawal symptoms (drawn from the literature) were assessed via computer-administered questionnaire. Subject groups were compared using chi-square or ANOVA. Symptom clustering was evaluated with principal components analysis.
40.9% of subjects met the DSM-V criterion of ≥3 symptoms from a list of 7. There were no associations with sex, race, or type of cannabis preparation used. There were significant positive associations between duration or frequency of cannabis use prior to the quit attempt and experiencing CWS. Subjects with CWS had a significantly shorter duration of abstinence. Alternative syndromal criteria (dropping physical symptoms from DSM-V list; requiring ≥2 or ≥4 symptoms from a list of 11) yielded a similar prevalence of CWS and similar associations with prior cannabis use and relapse. The PCA yielded 12 factors, including some symptom clusters not included in DSM-V.
Findings support the concurrent and predictive validity of the proposed DSM-V CWS, but suggest that the list of withdrawal symptoms and number required for diagnosis warrant further evaluation.
大麻戒断发生在经常使用大麻并停止使用的人群中,但目前还没有公认的大麻戒断综合征(CWS)的诊断标准。本研究评估了 DSM-V 中提出的以及两个早期提议的 CWS 诊断标准。
本研究便利抽样了 384 名成年、非治疗性、终身大麻使用者,这些参与者提供了他们未经正式治疗的“最困难”戒烟尝试的回顾性自我报告数据,这是本二次分析中使用的数据。通过计算机管理的问卷评估了 39 种戒断症状(从文献中提取)的发生率、发病时间和峰值强度(5 分李克特量表)。使用卡方检验或方差分析比较了不同组别。使用主成分分析评估了症状聚类情况。
40.9%的参与者符合 DSM-V 标准,即从 7 项症状列表中至少有 3 项症状。性别、种族或使用的大麻制剂类型与该标准无相关性。在戒烟尝试之前,大麻使用的持续时间或频率与出现 CWS 呈显著正相关。出现 CWS 的参与者戒断时间明显更短。替代综合征标准(从 DSM-V 列表中删除身体症状;需要从 11 项症状列表中至少有 2 项或 4 项症状)得出的 CWS 发生率相似,且与之前的大麻使用和复发情况存在相似的关联。主成分分析得出了 12 个因素,包括 DSM-V 中未包含的一些症状群。
研究结果支持了提议的 DSM-V CWS 的同时性和预测性有效性,但提示症状列表和所需的诊断数量需要进一步评估。